748731-75-1Relevant academic research and scientific papers
PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS
-
Paragraph 00405, (2013/05/22)
Compounds of Formula (I) and pharmaceutically acceptable salts thereof in which X1, X2, X3, L, R3, R4, R5, R7 and n have the meanings given in the specification, are modulators of GPR119 and are useful in the treatment or prevention of diseases such as such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.
BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF
-
Page/Page column 35, 36, (2010/07/09)
The present invention relates to Bicyclic Heterocycle Derivatives, compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a c
BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF
-
Page/Page column 197-198, (2009/05/30)
The present invention relates to Bicyclic Heterocycle Derivatives, compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR119 in a patient.
Substituted acylpiperazine derivatives
-
Page/Page column 20, (2008/06/13)
The invention relates to compounds of formula wherein the substituents are as defined in the specification and to pharmaceutically acceptable acid addition salts thereof. The invention further relates to methods for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.
